首页|甲状腺癌基础和临床研究现状和展望

甲状腺癌基础和临床研究现状和展望

扫码查看
甲状腺癌作为内分泌系统最常见的恶性肿瘤,其基础和临床研究备受关注。基础研究领域对甲状腺癌发病的分子机制探索不断深化,基因层面的研究发现,BRAF及RET等基因突变在甲状腺癌的发生发展中起着关键作用,且不同的突变类型与肿瘤的侵袭性和预后密切相关。对肿瘤微环境的研究揭示了免疫细胞、细胞因子等与癌细胞的相互作用,为免疫治疗策略提供了理论依据。临床研究方面,液体活检及人工智能算法结合蛋白质组学特征等诊断技术的应用提高了早期诊断的准确性。手术是甲状腺癌的最主要治疗手段,但手术方式仍在不断优化,应尽可能在治疗甲状腺疾病的同时尽可能保障甲状腺周围组织器官及甲状腺本身功能完整;药物治疗方面,靶向药物的出现为晚期或转移性甲状腺癌患者带来了新的希望,但药物的耐药性问题仍是挑战。
Review and prospect of basic and clinical research in thyroid cancer
As the most common malignant tumor of the endocrine system,thyroid cancer has at-tracted much attention in basic and clinical research.The exploration of the molecular mechanism of thyroid cancer pathogenesis in the field of basic research has been deepened,and studies at the gene level have found that gene mutations such as BRAF and RET play a key role in the occurrence and development of thyroid cancer,and different mutation types are closely related to the aggressiveness and prognosis of tumors.The study of tumor microenvironment reveals the interaction between immune cells and cytokines and cancer cells,and provides a theoretical basis for immunotherapy strategies.In terms of clinical re-search,the application of diagnostic technologies such as liquid biopsy and artificial intelligence algorithms combined with proteomic features has improved the accuracy of early diagnosis.Surgery is the most impor-tant treatment for thyroid cancer,but the surgical method is still being optimized,and the function of the surrounding tissues and organs and the thyroid gland itself should be protected as much as possible while treating thyroid diseases.In terms of drug therapy,the emergence of targeted drugs has brought new hope to patients with advanced or metastatic thyroid cancer,but drug resistance is still a challenge.

Thyroid cancerBasic researchClinical treatment

袁芊芊、吴高松

展开 >

武汉大学中南医院甲状腺乳腺外科,武汉 430071

甲状腺癌 基础研究 临床治疗

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(8)